Inflammatory Bowel Diseases

Inflammatory bowel diseases (IBDs) are chronic inflammatory disorders characterized by chronic relapsing inflammation of the gastrointestinal tract that affect 0.1% of Western populations, comprising two major forms, Crohn's disease (CD) and ulcerative colitis (UC). Adjuvants to the traditional therapy of inflammatory bowel disease (IBD) have been studied to enhance the efficacy of the treatment and improve patients’ quality of life. Approximately 1.6 million Americans currently have IBD, a growth of about 200,000 since the last time CCFA reported in 2011. As many as 70,000 new cases of IBD are diagnosed in the United States each year. There may be as many as 80,000 children in the United States with IBD. 

    Related Conference of Inflammatory Bowel Diseases

    December 17-18, 2018

    3rd World Liver Congress

    Abu Dhabi, UAE
    January 30-31, 2019

    16th World Congress on Gastroenterology & Therapeutics

    Bangkok, Thailand
    January 30-31, 2019 |

    World Congress on Pancreatic Cancer and Liver Diseases

    Radisson Hotel Narita | Tokyo, Japan
    March 04-05, 2019

    20th World Congress on Gastroenterology

    Berlin, Germany
    May 15-16, 2019

    21st World Congress on Advances in Gastroenterology and Hepatology

    Mercure Melbourne Albert Park, Melbourne, Australia
    June 17-18, 2019

    World Liver Conference 2019

    Columbus, Ohio, U.S.A
    July 08-09, 2019

    14th Euro-Global Gastroenterology Conference

    Zurich, Switzerland
    July 15-16, 2019

    7th International Conference on Hepatology

    Sydney, Australia
    September 23-24, 2019

    World Summit on Liver Cirrhosis and Hepatitis

    Tokyo, Japan
    October 14-15, 2019

    19th World Gastroenterologists Summit

    Sydney, Australia

    Inflammatory Bowel Diseases Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in